Chairman of the Qatar Cancer Society Named Among the 100 Most Influential Figures in Oncology for 2025
Al-Gisr – Exclusive
Chairman of Qatar Cancer Society Named Among the 100 Most Influential Figures in Oncology for 2025
The global platform OncoDaily, specialized in oncology, has announced the selection of Dr. Khalid bin Jaber Al Thani, Chairman of the Qatar Cancer Society, among the 100 most influential figures in oncology for 2025. This recognition honors his outstanding contributions to the development of cancer patient care, his leadership in supporting public health policies, and his efforts in strengthening the healthcare system. It also acknowledges his work in awareness campaigns, advocacy for cancer patients’ rights, medical education, and support for scientific research.
This prestigious international recognition reflects Qatar’s prominent position in the field of cancer control and highlights the influential global presence of Qatari health leaders in shaping health policies and advancing oncology services according to best international practices.
The achievement also underscores the vital role of the Qatar Cancer Society as a national model in supporting patients, raising community awareness, and building strategic local and international partnerships. These efforts enhance Qatar’s presence on global oncology platforms and support opportunities for collaboration and knowledge exchange with international institutions and organizations.
On this occasion, Dr. Khalid bin Jaber Al Thani expressed his deep pride in this recognition, emphasizing that it represents an acknowledgment of collective national efforts in cancer control rather than a personal achievement. He said:
“This international selection reflects the global medical community’s confidence in Qatar’s approach to developing an integrated healthcare system focused on prevention, early detection, and advanced treatment, placing the patient at the center of care, with the support of our wise leadership that prioritizes human health.”
He added:
“We view this recognition as a doubled responsibility that motivates us to continue developing our programs and services, and to strengthen national and international partnerships. Our goal is to provide comprehensive and sustainable support for cancer patients, survivors, and their families, improving their quality of life during treatment and after recovery.”
